Kineret 100 MG/0.67 ML syringe 0.67ML
Ended Awarded
- Contract number
- SPE2DB25FRXZE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,581
Award facts
- Contract value 100% obligated
- $3,580.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for the supply of Kineret (anakinra) 100 mg/0.67 mL syringes on May 28, 2025, with completion scheduled for June 18, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Kineret is a recombinant human interleukin-1 receptor antagonist used to treat rheumatoid arthritis and other inflammatory conditions, representing a specialized pharmaceutical need within the federal medical supply chain.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of federal medical procurement contracts covering a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's demonstrated capability to compete successfully across multiple therapeutic domains and fulfill federal medical supply requirements supports its role as a prime vendor within DLA's global pharmaceutical support network.
Quick answers
Who was awarded contract SPE2DB25FRXZE?
SPE2DB25FRXZE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 28, 2025.
How much is contract SPE2DB25FRXZE worth?
The government has obligated $3,581 on SPE2DB25FRXZE.
Is contract SPE2DB25FRXZE an order under another contract?
Yes. SPE2DB25FRXZE is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRXZE competed?
The extent of competition for SPE2DB25FRXZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award